NeuroFore
NeuroFore is pioneering the future of Parkinson's disease diagnostics by leveraging cutting-edge artificial intelligence to identify the disease years before traditional methods, focusing on early-stage, non-motor symptoms. Their innovative diagnostic application empowers healthcare providers with early intervention capabilities, aiming to transform patient care, improve quality of life, and reduce healthcare costs. They differentiate themselves by focusing on the critical pre-motor symptom phase, using a unique AI-driven approach to evaluate subtle, early non-motor symptoms for accurate and actionable results. Their mission is to bridge the diagnostic gap for Parkinson's disease, enabling early intervention and improved patient outcomes.
NeuroFore
NeuroFore is pioneering the future of Parkinson's disease diagnostics by leveraging cutting-edge artificial intelligence to identify the disease years before traditional methods, focusing on early-stage, non-motor symptoms. Their innovative diagnostic application empowers healthcare providers with early intervention capabilities, aiming to transform patient care, improve quality of life, and reduce healthcare costs. They differentiate themselves by focusing on the critical pre-motor symptom phase, using a unique AI-driven approach to evaluate subtle, early non-motor symptoms for accurate and actionable results. Their mission is to bridge the diagnostic gap for Parkinson's disease, enabling early intervention and improved patient outcomes.